2024 American Urological Association (AUA)
AUA 2024 Prostate Cancer
- AUA 2024: EvoPAR-Prostate01: Phase III, Double-Blind, Placebo-Controlled, 2-Cohort, Randomized Study of Saruparib (AZD5305) in Combination with New Hormonal Agents in Patients with mCSPC +/- HRR Mutations
- AUA 2024: Panel Discussion: Tricks and Tips of Penile Prosthesis Surgery
- AUA 2024: Evaluating AI Assistance in Prostate bpMRI Interpretation: A Multi-Reader Study
- AUA 2024: Crossfire: Controversies in Urology: Testosterone Therapy May Be Reasonably Offered to Men on Active Surveillance – Pro/Con
- AUA 2024: Crossfire: Controversies in Urology: Detrusor Underactivity in Men in Retention: To TURP or Not to TURP?
AUA 2024 Bladder Cancer
- AUA 2024: Back to Medical School: Immunology in NMIBC and Neoadjuvant MIBC for the Urologist
- AUA 2024: Panel Discussion: Interstitial Cystitis/ Systemic Therapy for Bladder Pain Syndrome: Which Patient and Which Therapy?
- AUA 2024: Can I use Markers and Imaging to Avoid Local Consolidation for Patient who has cT0 stage after Neoadjuvant Chemo or IO?
- AUA 2024: BCG Unresponsive Disease: How Much Risk can my Patient Tolerate?
- AUA 2024: Very High Risk NMIBC with Variant Histology
AUA 2024 Kidney Cancer
- AUA 2024: Evaluating the Efficacy of Robot-Assisted Fluoroscopic Renal Puncture in the Supine Position: A Global Multicenter First-in-Human Trial
- AUA 2024: A Multi-Institutional, Prospective Comparative Study Evaluating the Clinical Utility of IRIS, an Anatomical Modeling Software for Preoperative Surgical Planning and Intra-Operative Navigation During Robot Assisted Partial Nephrectomy
- AUA 2024: A Novel Urinary Biomarker for the Detection and Surveillance of Renal Cell Carcinoma
- AUA 2024: Renal Imaging for Active Surveillance: Have we Moved Past CT and MRI?
- AUA 2024: Radiation Oncology for RCC: Localized Disease, Oligometastatic Disease, and the Future
AUA 2024 Testicular and Penile Cancer
- AUA 2024: Accuracy of FDG-PET Scan in Primary Testicular Seminoma: Analysis from SEMS Trial
- AUA 2024: miRNA as a Liquid Biomarker to Detect Malignancy in Small Testicular Masses
- AUA 2024: Propensity-Matched Analysis of Open Versus Robotic Primary Retroperitoneal Lymph Node Dissection for CS II Testicular Cancer
AUA 2024 Upper Tract Urothelial Carcinoma
- AUA 2024: Debate: Lymph Node Dissection for Upper Tract Disease
- AUA 2024: Lymph Node Dissection for Upper Tract Disease
- AUA 2024: Exploring Recurrence After Initial Response to UGN-101 Induction in Expanded Settings
- AUA 2024: Sequential Endoluminal Gemcitabine and Docetaxel Versus Bacillus Calmette–Guérin for the Treatment of High-Grade Upper Tract Urothelial Carcinoma
- AUA 2024: Longitudinal Follow Up of Multicenter Study of UGN-101 for Upper Tract Urothelial Cancer
AUA 2024 Press Releases
- New Data Validating the First AI-Based Biomarker to Stratify Risk of Metastasis in Radical Prostatectomy Patients with Biochemical Recurrence
- UroGen Announces Results from ATLAS Showing Robust UGN-102 Durability of Response in New and Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer at AUA 2024
- Cretostimogene Monotherapy Demonstrated 75.2% Complete Response Rate in High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
- Bladder Cancer: Pivotal Trial Results and New Real-World Evidence, to Be Presented at AUA 2024, Demonstrate Improved Diagnostic and Clinical Outcomes with Blue Light Cystoscopy
AUA 2024 Lower Urinary Tract Conditions
- AUA 2024: Long-term Dementia Risk with Use of Anticholinergic versus Beta-3-Agonist Pharmacotherapy for Overactive Bladder
- AUA 2024: State-of-the-Art Lecture: The UTI Vaccine
- AUA 2024: Clear Urinary Tract Infection Protocol Improves Urology Staff and Provider Satisfaction
- AUA 2024: SOPHIA Study: The New Artificial Urinary Sphincter UroActive™: Results of the First in Man Study at 6 Months Post-Activation
AUA 2024 Endourology and Stone Disease
- AUA 2024: State-of-the-Art Lecture: Lasers in Endourology
- AUA 2024: Second Opinion Cases: Unable to Access Tight Ureter and UPJ Obstruction
- AUA 2024: State of the Art: Endocrinological Factors in the Etiology of Stone Disease
- AUA 2024: Paradigm-Shifting, Practice-changing Clinical Trials in Urology: Office-Based Removal of Small Urinary Stones
- AUA 2024: Direct In-Scope Suction: An in Vitro Evaluation of a Single-Use Flexible Ureteroscope with Integrated Suction Capability